{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T16:44:26Z","timestamp":1775839466395,"version":"3.50.1"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,13]],"date-time":"2013-05-13T00:00:00Z","timestamp":1368403200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0063338","type":"journal-article","created":{"date-parts":[[2013,5,13]],"date-time":"2013-05-13T21:08:17Z","timestamp":1368479297000},"page":"e63338","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Thymidylate Synthase Expression Determines Pemetrexed Targets and Resistance Development in Tumour Cells"],"prefix":"10.1371","volume":"8","author":[{"given":"Aitziber","family":"Buqu\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Unai","family":"Aresti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jangi","family":"Sh. Muhialdin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Carrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eider","family":"Azkona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itziar","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"L\u00f3pez-Vivanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,5,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drup.2012.07.002","article-title":"Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance","volume":"15","author":"N Gonen","year":"2012","journal-title":"Drug Resist Updat"},{"key":"ref2","article-title":"Cancer multidrug resistance","volume":"18","journal-title":"Nat Biotechnol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/0008-5472.CAN-10-1481","article-title":"DeltaNp63alpha confers tumor cell resistance to cisplatin through the AKT1 transcriptional regulation","volume":"71","author":"T Sen","year":"2011","journal-title":"Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jid.2008.379","article-title":"Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomide","volume":"129","author":"T Sinnberg","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"10853","DOI":"10.1073\/pnas.0804821105","article-title":"mTORC1 promotes survival through translational control of Mcl-1","volume":"105","author":"JR Mills","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/138920208785699571","article-title":"Expression and function of bcl-2 proteins in melanoma","volume":"9","author":"J Eberle","year":"2008","journal-title":"Curr Genomics"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"TSC2 mediates cellular energy response to control cell growth and survival","volume":"115","author":"K Inoki","year":"2003","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00280-009-1195-2","article-title":"Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines","volume":"66","author":"S Nannizzi","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"32081","DOI":"10.1074\/jbc.M502876200","article-title":"Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity","volume":"280","author":"A Hahn-Windgassen","year":"2005","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1365-2133.2007.07821.x","article-title":"Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment","volume":"156","author":"F Meier","year":"2007","journal-title":"Br J Dermatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1158\/0008-5472.CAN-08-4979","article-title":"Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition","volume":"69","author":"AC Racanelli","year":"2009","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.3816\/CLC.2004.s.003","article-title":"Pharmacology and mechanism of action of pemetrexed","volume":"5","author":"AA Adjei","year":"2004","journal-title":"Clin Lung Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1476-4598-11-25","article-title":"Molecular mechanism implicated in Pemetrexedinduced apoptosis in human melanoma cells","volume":"11","author":"A Buqu\u00e9","year":"2012","journal-title":"Mol Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1124\/mol.104.009373","article-title":"Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cells","volume":"68","author":"E Giovannetti","year":"2005","journal-title":"Mol Pharmacol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/sj.bjc.6604566","article-title":"Molecular pathways involved in the synergistic interaction of the PKC beta inhibitor enzastaurin with the antifolate pemetrexed in non-small cell lung cancer cells","volume":"99","author":"C Tekle","year":"2008","journal-title":"Br J Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10637-007-9060-9","article-title":"In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression","volume":"25","author":"AR Hanauske","year":"2007","journal-title":"Invest New Drugs"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1349-7006.2009.01358.x","article-title":"Significance of thymidylate synthase for resistance to pemetrexed in lung cancer","volume":"101","author":"H Ozasa","year":"2010","journal-title":"Cancer Sci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1008351221345","article-title":"Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors","volume":"11","author":"B Van Triest","year":"2000","journal-title":"Ann Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"39582","DOI":"10.1074\/jbc.M507443200","article-title":"5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase","volume":"280","author":"R Rattan","year":"2005","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/jid.2008.44","article-title":"Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells","volume":"128","author":"KG Lasithiotakis","year":"2008","journal-title":"J Invest Dermatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.1038\/sj.onc.1209097","article-title":"Akt-dependent transformation: there is more to growth than just surviving","volume":"24","author":"DR Plas","year":"2005","journal-title":"Oncogene"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1158\/0008-5472.CAN-05-0425","article-title":"Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway","volume":"66","author":"X Yang","year":"2006","journal-title":"Cancer Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"10299","DOI":"10.1158\/0008-5472.CAN-10-1873","article-title":"Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas","volume":"70","author":"SB Rothbart","year":"2010","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1158\/1535-7163.MCT-06-0001","article-title":"Methotrexate enhances the antianabolic and antiproliferative effects of 5-aminoimidazole-4-carboxamide riboside","volume":"5","author":"A Beckers","year":"2006","journal-title":"Mol Cancer Ther"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0063338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T17:51:27Z","timestamp":1595785887000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0063338"}},"subtitle":[],"editor":[{"given":"Sumitra","family":"Deb","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,13]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0063338","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,13]]}}}